The recent sell-off in major US stock indices has been largely driven by broader macroeconomic factors. Click to read.

Nasdaq 100, S&P 500, Dow Jones Industrial Average, Dow Jones Futures. Read 's Market Analysis on Investing.com ...

Under the market rebound, Oracle's under-the-radar nature offers traders a chance to scalp big profits out of ORCL stock call ...

SEATTLE, WA / ACCESS Newswire / April 22, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology ...

Corcept sees 40% growth in 2025 revenue with promising trials, expanded patient base, and strong projections. Read my ...

The S&P 500 entered a death cross about 10 days ago. It hasn’t been as good a strategy with stocks. On the opposite end of ...

Bithumb announces major corporate restructuring ahead of its planned IPO, spinning off non-exchange businesses into a new ...

ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to Placebo Cytisinicline New Drug Application (NDA) Submission ...

"The message from price action can be much more transparent than what you may read about in the financial press or see on ...

HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in gastric cancer ...

DelveInsight's "XADAGO/EQUFINA Market Size, Forecast, and Market Insight Report" highlights the details around XADAGO/EQUFINA ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...